Cargando…

Implementing Clinical Decision Support Tools and Pharmacovigilance to Reduce the Use of Potentially Harmful Medications and Health Care Costs in Adults With Heart Failure

Heart failure (HF) is associated with significant morbidity, mortality, compromised quality of life and socioeconomic burden worldwide. This chronic condition is becoming an increasingly important concern given the increased prevalence of HF among aging populations. Significant contributors toward e...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva Almodóvar, Armando, Nahata, Milap C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121021/
https://www.ncbi.nlm.nih.gov/pubmed/33995014
http://dx.doi.org/10.3389/fphar.2021.612941
_version_ 1783692240515760128
author Silva Almodóvar, Armando
Nahata, Milap C.
author_facet Silva Almodóvar, Armando
Nahata, Milap C.
author_sort Silva Almodóvar, Armando
collection PubMed
description Heart failure (HF) is associated with significant morbidity, mortality, compromised quality of life and socioeconomic burden worldwide. This chronic condition is becoming an increasingly important concern given the increased prevalence of HF among aging populations. Significant contributors toward escalating health care costs are emergency room visits and hospitalizations associated with HF. An important strategy to improve health care outcomes and reduce unnecessary costs is to identify and reduce the prescribing of potentially harmful medications (PHMs) among adults with HF. Previous studies in patients with HF found roughly 10–50% of them were prescribed at least one PHM in ambulatory care and inpatient health care settings. This opinion highlights recent findings from studies assessing prevalence of PHMs, associations between PHM prescribing and characteristics, and what can be done to improve patient outcomes and reduce the use of PHMs and associated health care costs in adults with HF.
format Online
Article
Text
id pubmed-8121021
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81210212021-05-15 Implementing Clinical Decision Support Tools and Pharmacovigilance to Reduce the Use of Potentially Harmful Medications and Health Care Costs in Adults With Heart Failure Silva Almodóvar, Armando Nahata, Milap C. Front Pharmacol Pharmacology Heart failure (HF) is associated with significant morbidity, mortality, compromised quality of life and socioeconomic burden worldwide. This chronic condition is becoming an increasingly important concern given the increased prevalence of HF among aging populations. Significant contributors toward escalating health care costs are emergency room visits and hospitalizations associated with HF. An important strategy to improve health care outcomes and reduce unnecessary costs is to identify and reduce the prescribing of potentially harmful medications (PHMs) among adults with HF. Previous studies in patients with HF found roughly 10–50% of them were prescribed at least one PHM in ambulatory care and inpatient health care settings. This opinion highlights recent findings from studies assessing prevalence of PHMs, associations between PHM prescribing and characteristics, and what can be done to improve patient outcomes and reduce the use of PHMs and associated health care costs in adults with HF. Frontiers Media S.A. 2021-04-30 /pmc/articles/PMC8121021/ /pubmed/33995014 http://dx.doi.org/10.3389/fphar.2021.612941 Text en Copyright © 2021 Silva Almodóvar and Nahata. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Silva Almodóvar, Armando
Nahata, Milap C.
Implementing Clinical Decision Support Tools and Pharmacovigilance to Reduce the Use of Potentially Harmful Medications and Health Care Costs in Adults With Heart Failure
title Implementing Clinical Decision Support Tools and Pharmacovigilance to Reduce the Use of Potentially Harmful Medications and Health Care Costs in Adults With Heart Failure
title_full Implementing Clinical Decision Support Tools and Pharmacovigilance to Reduce the Use of Potentially Harmful Medications and Health Care Costs in Adults With Heart Failure
title_fullStr Implementing Clinical Decision Support Tools and Pharmacovigilance to Reduce the Use of Potentially Harmful Medications and Health Care Costs in Adults With Heart Failure
title_full_unstemmed Implementing Clinical Decision Support Tools and Pharmacovigilance to Reduce the Use of Potentially Harmful Medications and Health Care Costs in Adults With Heart Failure
title_short Implementing Clinical Decision Support Tools and Pharmacovigilance to Reduce the Use of Potentially Harmful Medications and Health Care Costs in Adults With Heart Failure
title_sort implementing clinical decision support tools and pharmacovigilance to reduce the use of potentially harmful medications and health care costs in adults with heart failure
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121021/
https://www.ncbi.nlm.nih.gov/pubmed/33995014
http://dx.doi.org/10.3389/fphar.2021.612941
work_keys_str_mv AT silvaalmodovararmando implementingclinicaldecisionsupporttoolsandpharmacovigilancetoreducetheuseofpotentiallyharmfulmedicationsandhealthcarecostsinadultswithheartfailure
AT nahatamilapc implementingclinicaldecisionsupporttoolsandpharmacovigilancetoreducetheuseofpotentiallyharmfulmedicationsandhealthcarecostsinadultswithheartfailure